Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:51 AM
Ignite Modification Date:
2025-12-26 @ 11:51 AM
NCT ID:
NCT00055016
Eligibility Criteria:
* INCLUSION CRITERIA:
This registry is open for all patients of all ages, male and female, with a confirmed diagnosis of Fabry disease.
EXCLUSION CRITERIA:
Patients who are unwilling to give informed consent.
Patients who are receiving enzyme replacement therapy other than Replagal for Fabry Disease.
Patients currently enrolled in an ongoing blinded clinical trial in which the product is considered investigational.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00055016
Study Brief:
Protocol Section:
NCT00055016